Recombinant Human Erythropoietin (rhEPO) Market Forecast to 2027 - Covid-19 Impact and Global Analysis By Type (End Stage Renal Disease (ESRD), Cancer, HIV, Wounds and Neural Diseases); End User (Hospitals, Retail Pharmacies)

Report Code: TIPRE00016401 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Recombinant human erythropoietin (rhEPO) is a recombinant form of the hormone erythropoietin, is a hormone that enhances endogenous red blood cell production. rhEPO delivers higher hematocrit values and hemoglobin levels than transfusion alone in patients with cancer-related anemia. It is probably the most successful therapeutic application of recombinant DNA technology to date.

MARKET DYNAMICS

Recombinant human erythropoietin (rhEPO) market is driving due to the increasing prevalence of chronic conditions. However, the high cost of recombinant human erythropoietin (rhEPO) is hampering the market's growth. Moreover, growing awareness of benefits offered by these therapeutic proteins is expected to provide opportunities in the global recombinant human erythropoietin (rhEPO) market.

MARKET SCOPE

The "Recombinant Human Erythropoietin (rhEPO) Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Recombinant human erythropoietin (rhEPO) market with detailed market segmentation by type and end user. The Recombinant human erythropoietin (rhEPO) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Recombinant human erythropoietin (rhEPO) market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The recombinant human erythropoietin (rhEPO) market is segmented on the basis of type and end user. Based on type, the market is segmented as end stage renal disease (ESRD), cancer, HIV, wounds and neural diseases. Based on end user, the market is segmented as hospitals and retail pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the recombinant human erythropoietin (rhEPO) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant human erythropoietin (rhEPO) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting recombinant human erythropoietin (rhEPO) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Recombinant human erythropoietin (rhEPO) market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the recombinant human erythropoietin (rhEPO) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from recombinant human erythropoietin (rhEPO) market are anticipated to have lucrative growth opportunities in the future with the rising demand for recombinant human erythropoietin (rhEPO) in the global market. Below mentioned is the list of few companies engaged in the Recombinant human erythropoietin (rhEPO) market.

The report also includes the profiles of key players in recombinant human erythropoietin (rhEPO) market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- 3SBio
- Shanghai Chemo
- Chengdu Diao
- NCPC Genetech
- Kyowa Hakko Kirin
- Shandong Kexing
- Ahua Pharmaceutical
- Biosidus
- Dragon Pharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Human Erythropoietin (rhEPO) Market - By Type
1.3.2 Recombinant Human Erythropoietin (rhEPO) Market - By End User
1.3.3 Recombinant Human Erythropoietin (rhEPO) Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. END STAGE RENAL DISEASE (ESRD)
7.3.1. Overview
7.3.2. End Stage Renal Disease (ESRD) Market Forecast and Analysis
7.4. CANCER
7.4.1. Overview
7.4.2. Cancer Market Forecast and Analysis
7.5. HIV
7.5.1. Overview
7.5.2. HIV Market Forecast and Analysis
7.6. WOUNDS AND NEURAL DISEASES
7.6.1. Overview
7.6.2. Wounds and Neural Diseases Market Forecast and Analysis
8. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
9. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Recombinant Human Erythropoietin (rhEPO) Market Overview
9.1.2 North America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis
9.1.3 North America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Type
9.1.4 North America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By End User
9.1.5 North America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Countries
9.1.5.1 United States Recombinant Human Erythropoietin (rhEPO) Market
9.1.5.1.1 United States Recombinant Human Erythropoietin (rhEPO) Market by Type
9.1.5.1.2 United States Recombinant Human Erythropoietin (rhEPO) Market by End User
9.1.5.2 Canada Recombinant Human Erythropoietin (rhEPO) Market
9.1.5.2.1 Canada Recombinant Human Erythropoietin (rhEPO) Market by Type
9.1.5.2.2 Canada Recombinant Human Erythropoietin (rhEPO) Market by End User
9.1.5.3 Mexico Recombinant Human Erythropoietin (rhEPO) Market
9.1.5.3.1 Mexico Recombinant Human Erythropoietin (rhEPO) Market by Type
9.1.5.3.2 Mexico Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2. EUROPE
9.2.1 Europe Recombinant Human Erythropoietin (rhEPO) Market Overview
9.2.2 Europe Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis
9.2.3 Europe Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Type
9.2.4 Europe Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By End User
9.2.5 Europe Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.1.1 Germany Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.1.2 Germany Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2.5.2 France Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.2.1 France Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.2.2 France Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2.5.3 Italy Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.3.1 Italy Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.3.2 Italy Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2.5.4 Spain Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.4.1 Spain Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.4.2 Spain Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2.5.5 United Kingdom Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.5.1 United Kingdom Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.5.2 United Kingdom Recombinant Human Erythropoietin (rhEPO) Market by End User
9.2.5.6 Rest of Europe Recombinant Human Erythropoietin (rhEPO) Market
9.2.5.6.1 Rest of Europe Recombinant Human Erythropoietin (rhEPO) Market by Type
9.2.5.6.2 Rest of Europe Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Overview
9.3.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis
9.3.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.1.1 Australia Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.1.2 Australia Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3.5.2 China Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.2.1 China Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.2.2 China Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3.5.3 India Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.3.1 India Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.3.2 India Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3.5.4 Japan Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.4.1 Japan Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.4.2 Japan Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3.5.5 South Korea Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.5.1 South Korea Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.5.2 South Korea Recombinant Human Erythropoietin (rhEPO) Market by End User
9.3.5.6 Rest of Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market
9.3.5.6.1 Rest of Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market by Type
9.3.5.6.2 Rest of Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Overview
9.4.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis
9.4.3 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Recombinant Human Erythropoietin (rhEPO) Market
9.4.5.1.1 South Africa Recombinant Human Erythropoietin (rhEPO) Market by Type
9.4.5.1.2 South Africa Recombinant Human Erythropoietin (rhEPO) Market by End User
9.4.5.2 Saudi Arabia Recombinant Human Erythropoietin (rhEPO) Market
9.4.5.2.1 Saudi Arabia Recombinant Human Erythropoietin (rhEPO) Market by Type
9.4.5.2.2 Saudi Arabia Recombinant Human Erythropoietin (rhEPO) Market by End User
9.4.5.3 U.A.E Recombinant Human Erythropoietin (rhEPO) Market
9.4.5.3.1 U.A.E Recombinant Human Erythropoietin (rhEPO) Market by Type
9.4.5.3.2 U.A.E Recombinant Human Erythropoietin (rhEPO) Market by End User
9.4.5.4 Rest of Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market
9.4.5.4.1 Rest of Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market by Type
9.4.5.4.2 Rest of Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Recombinant Human Erythropoietin (rhEPO) Market Overview
9.5.2 South and Central America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis
9.5.3 South and Central America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Type
9.5.4 South and Central America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By End User
9.5.5 South and Central America Recombinant Human Erythropoietin (rhEPO) Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Recombinant Human Erythropoietin (rhEPO) Market
9.5.5.1.1 Brazil Recombinant Human Erythropoietin (rhEPO) Market by Type
9.5.5.1.2 Brazil Recombinant Human Erythropoietin (rhEPO) Market by End User
9.5.5.2 Argentina Recombinant Human Erythropoietin (rhEPO) Market
9.5.5.2.1 Argentina Recombinant Human Erythropoietin (rhEPO) Market by Type
9.5.5.2.2 Argentina Recombinant Human Erythropoietin (rhEPO) Market by End User
9.5.5.3 Rest of South and Central America Recombinant Human Erythropoietin (rhEPO) Market
9.5.5.3.1 Rest of South and Central America Recombinant Human Erythropoietin (rhEPO) Market by Type
9.5.5.3.2 Rest of South and Central America Recombinant Human Erythropoietin (rhEPO) Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RECOMBINANT HUMAN ERYTHROPOIETIN (RHEPO) MARKET, KEY COMPANY PROFILES
12.1. 3SBIO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SHANGHAI CHEMO
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CHENGDU DIAO
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NCPC GENETECH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. KYOWA HAKKO KIRIN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SHANDONG KEXING
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AHUA PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOSIDUS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DRAGON PHARMA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. 3SBio
2. Shanghai Chemo
3. Chengdu Diao
4. NCPC Genetech
5. Kyowa Hakko Kirin
6. Shandong Kexing
7. Ahua Pharmaceutical
8. Biosidus
9. Dragon Pharma
TIPRE00016401
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking